We are live on ! Find out more
BFRA

Biofrontera AG American Depositary Shares

Delisted

BFRA was delisted on the 4th of March, 2022.

5 hedge funds and large institutions have $216K invested in Biofrontera AG American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

29% less capital invested

Capital invested by funds: $306K → $216K (-$90K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$33.4K
2
Citadel Advisors
Citadel Advisors
Florida
-$14.6K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$76K -$33.4K -5,662 -28%
1CM
2
1492 Capital Management
Wisconsin
$69K +$631 +107 +0.9%
Citadel Advisors
3
Citadel Advisors
Florida
$59K -$14.6K -2,475 -19%
UBS Group
4
UBS Group
Switzerland
$11K +$1.01K +171 +9%
Osaic Holdings
5
Osaic Holdings
Arizona
$1K

BFRA Hedge Fund Activity: Q3 2021 in Review

5 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q3 2021, worth a combined $216K — down 29% from $306K a quarter earlier.

Fund positioning in BFRA was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, adding an estimated $1.01K. The largest seller was Morgan Stanley, cutting an estimated $33.4K.

  • 5 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $216K of Biofrontera AG American Depositary Shares stock for Q3 2021, down 29% quarter-over-quarter.
  • 0 funds opened new Biofrontera AG American Depositary Shares positions in Q3 2021 and 0 closed out.
  • The largest Biofrontera AG American Depositary Shares buyer in Q3 2021 was UBS Group, an estimated $1.01K added.
  • The largest Biofrontera AG American Depositary Shares seller in Q3 2021 was Morgan Stanley, an estimated $33.4K sold.

Based on aggregated 13F filings for Q3 2021.